Probiotics, dendritic cells and bladder cancer

BJU International

Volumn 109, Issue 11, 2012, Pages 1594-1597

  Feyisetan, Oladapo ^a   Tracey, Christopher ^b   Hellawell, Giles O ^a  

^a EALING HOSPITAL NHS TRUST   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

bladder cancer; dendritic cells; probiotics

Indexed keywords

BCG VACCINE; PROBIOTIC AGENT;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BACTERIAL COLONIZATION; BLADDER CANCER; BLADDER SURGERY; BLADDER TUMOR; CANCER STAGING; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; CLINICAL TRIAL (TOPIC); COLON FLORA; COLORECTAL CANCER; CYTOKINE RELEASE; DENDRITIC CELL; EVIDENCE BASED MEDICINE; FERMENTED PRODUCT; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; REVIEW; STREPTOCOCCUS SALIVARIUS; TRANSURETHRAL RESECTION OF BLADDER TUMOR; UNITED KINGDOM;

ANIMALS; DENDRITIC CELLS; HUMANS; LACTOBACILLUS; PROBIOTICS; URINARY BLADDER NEOPLASMS;

EID: 84860620378     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10749.x     Document Type: Review

References (20)

1. Babjuk M, Oosterlinck W, Sylvester R, et al,. EAU guidlines non-muscle invasive bladder cancer (TaT1and CIS). 2011. Available at:. Accessed October 2011
2. Dunn GP, Old LJ, Schreiber RD,. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004; 21: 137-48 (Pubitemid 39094044)
3. Banchereau J, Steinman RM,. Dendritic cells and the control of immunity. Nature 1998; 392: 245-52 (Pubitemid 28155090)
4. Darouiche RO, Thornby JI, Cerra-Stewart C, Donovan WH, Hull RA,. Bacterial interference for prevention of urinary tract infection: a prospective, randomized, placebo-controlled, double-blind pilot trial. Clin Infect Dis 2005; 41: 1531-4 (Pubitemid 41580001)
5. Gionchetti P, Rizzello F, Venturi A, et al,. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305-9 (Pubitemid 30621980)
6. Schrezenmeir J, de Vrese M,. Probiotics, prebiotics, and synbiotics-approaching a definition. Am J Clin Nutr 2001; 73 (Suppl.): 361S-364S (Pubitemid 32113256)
7. Aso Y, Akazan H,. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group. Urol Int 1992; 49: 125-9
8. Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC,. Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis 2009; 15: 300-10
9. Matsuzaki T, Chin J,. Modulating immune responses with probiotic bacteria. Immunol Cell Biol 2000; 78: 67-73 (Pubitemid 30090991)
10. Mohamadzadeh M, Olson S, Kalina WV, et al,. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad of Sci USA 2005; 102: 2880-5 (Pubitemid 40299885)
11. Drakes M, Blanchard T, Czinn S,. Bacterial probiotic modulation of dendritic cells. Infect Immun 2004; 72: 3299-309 (Pubitemid 38697752)
12. Hart AL, Lammers K, Brigidi P, et al,. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004; 53: 1602-9 (Pubitemid 39434103)
13. Christensen HR, Frøkiaer H, Pestka JJ,. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002; 168: 171-8 (Pubitemid 34014116)
14. Wen Z, Fiocchi C,. Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis? Clin Dev Immunol 2004; 11: 195-204 (Pubitemid 39423298)
15. van den Broeke LT, Daschbach E, Thomas EK, Andringa G, Berzofsky JA,. Dendritic cell-induced activation of adaptive and innate antitumor immunity. J Immunol 2003; 171: 5842-52 (Pubitemid 37467201)
16. Asano M, Karasawa E, Takayama T,. Antitumor activity of Lactobacillus casei (LC 9018) against experimental mouse bladder tumor (MBT-2). J Urol 1986; 136: 719-21 (Pubitemid 16012520)
17. Lim BK, Mahendran R, Lee YK, Bay BH,. Chemopreventive effect of Lactobacillus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the mouse. Jpn J Cancer Res 2002; 93: 36-41 (Pubitemid 34144710)
18. Takagi A, Matsuzaki T, Sato M, Nomoto K, Morotomi M, Yokokura T,. Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism. Carcinogenesis 2001; 22: 599-605 (Pubitemid 32288661)
19. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S,. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol 1995; 27: 104-9
20. Naito S, Koga H, Yamaguchi A, et al,. Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer. J Urol 2008; 179: 485-90